Patient perspectives on living with severe asthma in Denmark and Sweden

References

• Global Asthma Network. The global asthma report 2019. Available from: GINA-2019-main-report-June-2019-wms.pdf
   Google Scholar
• Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343–7.
   PubMed Web of Science ®Google Scholar
• To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12(1):204.
   PubMed Web of Science ®Google Scholar
• O’Byrne PM, Pedersen S, Schatz M, et al. The poorly explored impact of uncontrolled asthma. Chest. 2013;143(2):511–523.
   PubMed Web of Science ®Google Scholar
• von Bulow A, Kriegbaum M, Backer V, et al. The prevalence of severe asthma and low asthma control among Danish adults. J Allergy Clin Immunol Pract. 2014;2(6):759–767.
   PubMed Web of Science ®Google Scholar
• Larsson K, Ställberg B, Lisspers K, et al. Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR). Respir Res. 2018;19(1):12.
   PubMed Web of Science ®Google Scholar
• Nunes C, Pereira AM, Morais-Almeida M. Asthma costs and social impact. Asthma Res Pract. 2017;3:1.
   PubMedGoogle Scholar
• Jansson SA, Backman H, Andersson M, et al. Severe asthma is related to high societal costs and decreased health related quality of life. Respir Med. 2020;162:105860.
   PubMed Web of Science ®Google Scholar
• Menzies-Gow A, Canonica G-W, Winders TA, et al. A charter to improve patient care in severe asthma. Adv Ther. 2018;35(10):1485–1496.
   PubMed Web of Science ®Google Scholar
• Hyland ME, Whalley B, Jones RC, et al. A qualitative study of the impact of severe asthma and its treatment showing that treatment burden is neglected in existing asthma assessment scales. Qual Life Res. 2015;24(3):631–639.
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Duh MS, Lafeuille M-H, et al. Acute and chronic systemic corticosteroid-related complications in patients with severe asthma. J Allergy Clin Immunol. 2015;136(6):1488–1495.
   PubMed Web of Science ®Google Scholar
• Zazzali JL, Broder MS, Omachi TA, et al. Risk of corticosteroid-related adverse events in asthma patients with high oral corticosteroid use. Allergy Asthma Proc. 2015;36(4):268–274.
   PubMed Web of Science ®Google Scholar
• Volmer T, Effenberger T, Trautner C, et al. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature. Eur Respir J. 2018;52(4):1800703. doi:https://doi.org/10.1183/13993003.00703-2018. PMID: 30190274.
   Google Scholar
• Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204.
   PubMed Web of Science ®Google Scholar
• Voorham J, Xu X, Price DB, et al. Healthcare resource utilization and costs associated with incremental systemic corticosteroid exposure in asthma. Allergy. 2019;74(2):273–283. doi:https://doi.org/10.1111/all.13556. Epub 2018 Nov 20. PMID: 29987879; PMCID: PMC6587525.
   Web of Science ®Google Scholar
• Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113(1):59–65.
   PubMed Web of Science ®Google Scholar
• Available from: https://sites.dundee.ac.uk/vitalbe/wp-content/uploads/sites/120/2019/08/VitalBE-St-Georges-Respiratory-Questionnaire-V2-12-02-2019-1.pdf
   Google Scholar
• Kritikos V, Price D, Papi A, et al. A multinational observational study identifying primary care patients at risk of overestimation of asthma control. NPJ Prim Care Respir Med. 2019;29(1):43.
   PubMed Web of Science ®Google Scholar
• Chung LP, Hew M, Bardin P, et al. Managing patients with severe asthma in Australia: current challenges with the existing models of care. Intern Med J. 2018;48(12):1536–1541.
   PubMed Web of Science ®Google Scholar
• Nwaru BI, Ekström M, Hasvold P, et al. Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme. Eur Respir J. 2020;55(4):1901872.
   Web of Science ®Google Scholar
• Ekstrom M, Nwaru BI, Hasvold P, et al. Oral corticosteroid use, morbidity and mortality in asthma: A nationwide prospective cohort study in Sweden. Allergy. 2019;74(11):2181–2190.
   PubMed Web of Science ®Google Scholar
• Eisner MD, Yelin EH, Katz PP, et al. Risk factors for work disability in severe adult asthma. Am J Med. 2006;119(10):884–891. doi:https://doi.org/10.1016/j.amjmed.2006.01.016. PMID: 17000221.
   PubMed Web of Science ®Google Scholar
• Taponen S, Lehtimäki L, Karvala K, et al. Correlates of employment status in individuals with asthma: a cross-sectional survey. J Occup Med Toxicol. 2017;12(1):19.
   Web of Science ®Google Scholar
• Stridsman C, Romberg K, Binnmyr J, et al. Ge patienter med astma ökad rätt till behandling och uppföljning. Läkartidningen. 2020;117:FY7W Available from: https://lakartidningen.se/opinion/debatt/2020/02/patienter-med-astma-bor-fa-okad-ratt-till-behandling-och-uppfoljning/
   Google Scholar
• Porsbjerg C, Ulrik C, Skjold T, et al. Nordic consensus statement on the systematic assessment and management of possible severe asthma in adults. Eur Clin Respir J. 2018;5(1):1440868.
   PubMed Web of Science ®Google Scholar
• Hekking PP, Amelink M, Wener RR, et al. Comorbidities in difficult-to-control asthma. J Allergy Clin Immunol Pract. 2018;6(1):108–113.
   PubMed Web of Science ®Google Scholar
• Tattersall MC, Guo M, Korcarz CE, et al. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(6):1520–1525.
   PubMed Web of Science ®Google Scholar
• Mancuso CA, Wenderoth S, Westermann H, et al. Patient-reported and physician-reported depressive conditions in relation to asthma severity and control. Chest. 2008;133(5):1142–1148.
   PubMed Web of Science ®Google Scholar
• Amelink M, Hashimoto S, Spinhoven P, et al. Anxiety, depression and personality traits in severe, prednisone-dependent asthma. Respir Med. 2014;108(3):438–444. doi:https://doi.org/10.1016/j.rmed.2013.12.012. Epub 2014 Jan 2. PMID: 24462260.
   Web of Science ®Google Scholar
• Fuseini H, Newcomb DC. Mechanisms driving gender differences in asthma. Curr Allergy Asthma Rep. 2017;17(3):19.
   PubMed Web of Science ®Google Scholar